HUNTINGTON'S DISEASE

Clinical trials for HUNTINGTON'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new HUNTINGTON'S DISEASE trials appear

Sign up with your email to follow new studies for HUNTINGTON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 2 Completed 3 Terminated 2

Hope for Huntington's: new drug aims to slow decline in major trial

Disease control Not yet recruiting

This study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …

Matched conditions: HUNTINGTON'S DISEASE

Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

HUNTINGTON'S DISEASE

Get alerted when new HUNTINGTON'S DISEASE trials appear

Hope for Huntington's: new drug aims to slow decline in major trial